Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Am J Clin Oncol. 2014 Dec;37(6):528–534. doi: 10.1097/COC.0b013e31827defa1

Table 2.

Best response in patients with metastatic disease receiving chemotherapy (RECIST 1.0).

Best Result (RECIST 1.0)
Regimen N° of pts PR SD PD
Osteosarcoma-like 6 1 5
Anthracycline monotherapy* 4 1 1 2
Paclitaxel 2 1 1
Cisplatin-etoposide 1 1
Unknown 2
*

Standard doxorubicin or pegylated liposomal doxorubicin